Journal of Gastroenterology

Papers
(The TQCC of Journal of Gastroenterology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom115
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus75
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism73
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers68
Bifidobacterium bifidum CIP-01 attenuates metabolic dysfunction-associated steatotic liver disease induced by high-alcohol-producing Klebsiella pneumoniae62
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis61
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease56
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma54
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy49
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study49
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy46
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv44
Single-cell transcriptomics unveils the immunologic landscape of anti-PD-1-associated indirect drug-induced liver injury39
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy39
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan37
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial36
Hic-5 deficiency attenuates MAFLD by inhibiting neutrophils migration via the CXCL1-CXCR2 axis36
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data36
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy35
Clinicopathological features of localized-type IgG4-related cholecystitis: a nationwide multicenter study in Japan33
Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan32
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials32
Clinical practice guidelines for duodenal cancer 202132
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma31
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database31
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices30
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis30
Acknowledgements29
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey29
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan28
Correction: Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)28
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis27
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan27
Current status and trends in ERCP and post-ERCP pancreatitis in Japan: a nationwide observational study26
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?25
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 202125
Evaluating liver reserve in direct-acting antiviral-treated hepatitis C patients: do we have better surrogate markers?24
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis24
Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)24
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study23
Letter to “Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis”23
Is it necessary for endoscopic surveillance for achalasia patients?22
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation22
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia22
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime21
Volatomics-based biomarkers for non-invasive diagnosis and monitoring of inflammatory bowel disease21
Targeting autophagy as a therapeutic strategy against pancreatic cancer21
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study21
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma20
Reply to “Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data”20
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials20
Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study20
Extracellular vesicle-encapsulated microRNA-425 promotes tumor development and serves as a biomarker for pancreatic ductal adenocarcinoma19
An interpretable machine learning model for predicting survival in pancreatic cancer via SHAP: a multicenter study19
Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-1919
Clinicopathological features and prognosis of metastatic tumors in the small bowel: a large multicenter analysis of the JSCCR database in Japan18
“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection18
Management of MASLD/MASH: challenges, innovations, and the future of patient-centered care in Japan18
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases18
Checking the shape of hepatocellular carcinoma: how irregular is irregular?18
Letter to the editor to ‘‘Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis’’18
Gastric cancer and genomics: review of literature17
Cancer pathways in serrated polyposis syndrome: is conventional more crucial than serrated?17
VPS45 promotes the progression of hepatocellular carcinoma by recycling β1 integrin to the cell membrane via the endocytic pathway17
RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer17
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)16
Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”16
Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases16
Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease15
HLA-DQB1*03:01 and HLA-DQA1*05:05 as key genetic determinants of infliximab response and immunogenicity in Japanese patients with inflammatory bowel disease15
Correction: Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multic15
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society15
Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn’s disease in Japan in 202315
Molecular imaging of gastrointestinal stromal tumor using anti-c-KIT antibody and its fragments14
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation14
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia14
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention14
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry14
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis14
AI-assisted diagnosis of Helicobacter pylori infection: strengths, limitations, and future directions14
Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma14
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development14
Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912)14
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy14
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy13
Validation of novel scoring systems for acute decompensated cirrhosis identifies PBC as an independent poor prognostic factor: a single-center Japanese cohort study13
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan13
Reply to “Comment on: Long-term evaluation of Helicobacter pylori screening in school health checkups: an 11-year study in Japan”13
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY13
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation13
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance13
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia13
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer13
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy13
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando13
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis12
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study12
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance12
Renal manifestations in inflammatory bowel disease: a systematic review12
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data12
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study11
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study11
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer11
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma11
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease11
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis11
Acknowledgements11
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer11
Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia11
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia11
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis10
Hepatocyte-specific yes-associated protein knockout exacerbates non-alcoholic steatohepatitis by upregulating PCSK910
Prognostic value of functional assessment in sarcopenia among pancreatic cancer patients10
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy10
Targeting the ZDHHC9-mediated STAT1 palmitoylation-phosphorylation conversion inhibits gastric cancer progression10
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”10
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors10
The antiferroptotic effect of indigo on ulcerative colitis10
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-co10
Letter to "The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trial"10
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer10
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy10
Cost–utility analysis of treatment strategies for chronic constipation in Japan9
Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients9
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection9
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study9
Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis9
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus9
Comment on “Escherichia coli as a gut microbial marker of obesity and its reduction following bariatric treatment”: ecological and functional perspectives9
Acknowledgements9
Identification of the distal end of the palisade vessels under sedation: a multicenter prospective study in Japan9
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma9
Clarifying diagnostic scope and future perspectives in AI-assisted diagnosis of Helicobacter pylori infection9
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenoc9
Differences in adult eosinophilic esophagitis between Japan and Western countries9
Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn’s disease9
Current status of type 1 (IgG4-related) autoimmune pancreatitis9
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer9
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”9
Growing evidence on the highly sensitive iTACT assay of hepatitis B core-related antigen for predicting hepatitis B virus reactivation9
Single-cell transcriptomics reveals hypoxia-driven iCAF_PLAU is associated with stemness and immunosuppression in anorectal malignant melanoma9
Predictors of lymph node metastases, recurrence, and survival in patients with pedunculated-type T1 colorectal cancer9
0.085536003112793